EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unlocking Lung Cancer Cell Dormancy: An Epigenetic Perspective

Federico Pio Fabrizio iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262210997 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Federico Pio Fabrizio. Beteiligte Einrichtung: Department of Medicine and Surgery, "Kore" University of Enna, 94100 Enna, Italy. Hauptthemen laut MEDLINE: Lung Neoplasms, Epigenesis, Genetic, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer remains one of the leading causes of cancer-related mortality worldwide, with tumor recurrence and metastasis posing significant challenges despite advances in targeted therapies and immunotherapy. Cellular dormancy, a reversible, quiescent state marked by cell cycle arrest, has emerged as a key driver of therapeutic resistance and disease relapse, particularly in small-cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Multiple mechanisms, including autophagy, stress-adaptive signaling, microenvironmental cues, and epigenetic dysregulation, have been implicated in the regulation of dormancy and long-term cell survival. Among these, epigenetic modifications such as DNA methylation, histone modifications, and non-coding RNAs (ncRNAs) play pivotal roles in maintaining dormancy by repressing proliferative gene expression programs. Increasing evidence suggests that dormant tumor cells harbor distinct epigenomic signatures, which may serve as predictive biomarkers for minimal residual disease (MRD) and relapse risk. This review summarizes current advances in understanding the epigenetic regulation of cellular dormancy in lung cancer, with a particular emphasis on the interplay between epigenetic modifiers and oncogenic signaling pathways. Furthermore, emerging molecular targets and associated therapeutic agents currently under clinical evaluation are presented, emphasizing how a deeper understanding of the epigenetic landscape governing dormancy may inform the development of novel interventions to improve long-term clinical outcomes in lung cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsEpigenesis, GeneticCarcinoma, Non-Small-Cell LungHumansGene Expression Regulation, NeoplasticDNA MethylationAnimalsSignal Transduction

Stichwörter der Autor:innen

DNA methylationepigeneticslung cancerminimal residual diseasetherapy resistancetumor dormancy

Autor:innen und Institutionen

  • Department of Medicine and Surgery, "Kore" University of Enna, 94100 Enna, Italy.

ORCID-Profile: Federico Pio Fabrizio

Zitieren

APA

Fabrizio, F. P. (2025). Unlocking Lung Cancer Cell Dormancy: An Epigenetic Perspective. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262210997

Vancouver

Fabrizio FP. Unlocking Lung Cancer Cell Dormancy: An Epigenetic Perspective. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262210997

BibTeX
@article{Fabrizio2025,
  author = {Fabrizio, Federico Pio},
  title = {Unlocking Lung Cancer Cell Dormancy: An Epigenetic Perspective},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262210997}
}
Kostenlos starten →